Eskbiochem SA de CV Warning Letter Details

Summary

Based on limited metadata, the FDA issued a Warning Letter to Eskbiochem SA de CV, a pharmaceutical company, on July 23, 2020, regarding drug products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in this metadata.